Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCM-CGH in steroid-refractory/dependent cGVHD
NCT04189432Phase 2Unknown
- Sponsor
- SCM Lifescience Co., Ltd.
- Start
- Sep 2016
- Primary completion
- Mar 2024
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of SCM-AGH in chronic graft-versus-host disease (cGVHD), sponsored by SCM Lifescience Co., Ltd.. Status: unknown.
02
Drugs
SCM-AGH
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on NCT04189432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04189432.